Product Information
TETRACYCLINE 250 MG CAPSULE is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2462 per EA under NDC 23155076601. Its NADAC has been published 324 times since Jun 10, 2020.
FDA first approved this application on Aug 12, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Tetracycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155076601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TETRACYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA062752FDA Approved
8/12/1988
TE Code
AB
On Market Since
4/1/2020
Pharmacological Classes
Price Statistics
The NADAC for TETRACYCLINE 250 MG CAPSULE has been published 324 times since Jun 10, 2020, and over the history we have for it it has declined 80.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2462 per EA |
|---|---|
| All-time high | $1.2444 (Dec 16, 2020) |
| All-time low | $0.2462 (Aug 19, 2026) |
| 52-week high | $0.7024 |
| 52-week low | $0.2462 |
| Median price | $0.7011 |
| Average price | $0.7562 |
| Largest weekly change | +72.0% (Sep 22, 2021) |
| Weeks tracked | 324 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TETRACYCLINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 250 MG CAPSULE, manufactured by Heritage Pharmaceuticals Inc., is $0.2462 per EA (NDC 23155076601), effective Aug 19, 2026.
How has the price of TETRACYCLINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TETRACYCLINE 250 MG CAPSULE has declined 80.2%. It has been tracked across 324 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for TETRACYCLINE 250 MG CAPSULE?
Since Jun 10, 2020, the NADAC for TETRACYCLINE 250 MG CAPSULE has ranged from a low of $0.2462 (Aug 19, 2026) to a high of $1.2444 (Dec 16, 2020), with a median of $0.7011 per EA.
Are there cheaper alternatives to TETRACYCLINE 250 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TETRACYCLINE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TETRACYCLINE 250 MG CAPSULE?
TETRACYCLINE 250 MG CAPSULE (NDC 23155076601) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.